Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
EYEN $4.60--FDA Decision in October ..stock could hit $8-10 even before pdufa date
you call a $4.7 billion one trick pony company a bargain ?
put EYEN & ETTX in your portfolio both biotech are very cheap and big milestones around the corner ...EYEN with FDA decision in October and ETTX about to release Phase 3 data in the coming weeks
(RVPH) MC $52 m--Cash $36 m --HUGE Product pipeline with mutliple potential blockbusters ..Partnership is one of their big milestones before year end . RVPH is another very HOT and dirt cheap biotech guys with huge upside .
Check out their presentation
https://ir.revivapharma.com/static-files/99decd3b-43df-4496-87f9-7bc4bf2f8f07
EYEN with big insider buying...its a great stock toown ahead the FDA decision in october
https://www.secform4.com/insider-trading/1682639.htm
EYEN $4.35 --FDA Decision in 2 months could run to$10 ahead of the fda meeting
RVPH EXPLODINGGGGGGGGGGGGG
RVPH about to EXPLODEEEE
ETTX $2.60--BIG Phase 3 data imminent expected early october ,could run to $10 and higher on positive outcome
out of ABVC and added more ETTX which is close to release phase 3 data
(ETTX) $2.46--2x BIG Phase 3 readouts imminent first one in early October if positive this stock could explode to $10 in no time
ABVC rallyyyyyyyyyyyyy
ABVC up 12% ,,attractive low float biotech with huge product pipeline --market cap only $60million
VLON movinggggg .MC 27 m -float 3 m -- 2x BIG drugs NEAR approval a potential 10 bagger her
VLON about to EXPLODEE like VRPX anytime now
(ARDS) $3.70--MCap $52m--2xPhase 3 Drugs alsoahot covid play,,,Management bought shares above $4.80...any good news here will push the stockto $10 and higher
Insider buying
https://www.secform4.com/insider-trading/1614067.htm
ABVC very cheap low float biotech with HUGE pipeline see link below
https://abvcpharma.com/?page_id=16692
NLSP movingggg another low float biotech
VLON start movingggggg
ABVC $2.25 heavily oversold stock looking for strong rebound
VLON much better gem than VRPX has way better Pipeline has similar oustanding shares
EYEN & ETTX hottest biotechs for October EYEN $4.20 has FDA Decision in October and ETTX $2.50 about torelease final Phase 3 data in October ,, both underpriced stocks could start running ahead of those milestones..
(ACOGF) 0.74-PHASE 3 ALZHEIMER stock with potential BEST in CLASS treatment ..Phase 3 readout expected within 8 months ..this UNKNOWN stock is a lifetime opp just look at SAVA and ANVS andyou will know why Alzheimer stocks are hot ..
Alpha Cognition is undervalued, says Raymond James
https://www.cantechletter.com/2021/06/alpha-cognition-is-undervalued-says-raymond-james/
Alpha-1062 Could Become A Best In Class Treatment Option for Patients Suffering from Alzheimer's Disease
https://www.benzinga.com/general/biotech/21/07/22140880/alpha-cognition-is-a-clinical-stage-biopharmaceutical-company-dedicated-to-developing-treatments-
$MTCR 3.30 about to Breakout ( more about the stock see my previous post )
(MTCR) $3.20--Blockbuster Phase 2 NASH data in October ,stock trading at cash level ..if data readout is positive thestock could explode toward 20 dollars becauseNASH marketis very large and there is still NO approved treatment for the disease
https://assets.wallstreet-online.de/_media/8763/board/20210628170130-screenshot-2021-06-28-at-17-01-07-powerpoint-pres.png
Nice rebound at ABVC
(ABVC) good entry at $2.50,,new listed nasdaq biotech with attractive prdocut pipeline
(ACOGF) 0.75-PHASE 3 ALZHEIMER stock with potential BEST in CLASS treatment ..Phase 3 readout expected within 8 months ..this UNKNOWN stock is a lifetime opp just look at SAVA and ANVS andyou will know why Alzheimer stocks are hot ..
Alpha Cognition is undervalued, says Raymond James
https://www.cantechletter.com/2021/06/alpha-cognition-is-undervalued-says-raymond-james/
Alpha-1062 Could Become A Best In Class Treatment Option for Patients Suffering from Alzheimer's Disease
https://www.benzinga.com/general/biotech/21/07/22140880/alpha-cognition-is-a-clinical-stage-biopharmaceutical-company-dedicated-to-developing-treatments-